Frontlight ResearchEarly access
Trial site
University of California, Los Angeles (UCLA) - Medical Center
- 3running trials
- 3closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Diffuse large B-cell lymphoma2 trials
- Follicular lymphoma2 trials
- Hodgkin lymphoma1 trial
- Lung cancer1 trial
- Lupus (SLE)1 trial
- Mesothelioma1 trial
- Myeloproliferative neoplasms1 trial
- Phase
- Phase 1/22 trials
- Phase 32 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Completed2 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Withdrawn1 trial
- Lead sponsor
- Lyell Immunopharma, Inc.2 trials
- Eli Lilly and Company1 trial
- Ferring Ventures Limited1 trial
- Protagonist Therapeutics, Inc.1 trial
- Syndax Pharmaceuticals1 trial
Running trials
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diffuse large B-cell lymphoma2 recruiting
- Follicular lymphoma2 recruiting
- Hodgkin lymphoma1 recruiting
Closed trials
Withdrawn
A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
Recruiting
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026